Undruggable

Certain diseases, including Alzheimer's, are currently considered "undruggable" because traditional small molecule drugs can't interfere with the proteins responsible for the illnesses. But a new technique that specifically targets and…

<!-- Name:DistributionId Value:8741407 --> <!-- Name:EnableQuoteCarouselOnPnr Value:False --> <!-- Name:IcbCode Value: -->…

Collaboration allows Hillstream to enter the rapidly growing Immuno-oncology therapeutics market By capitalizing on the long half-life of tumor targeting Quatramers™ combined with OmniTaur™-derived Picobodies™, the lead program, HSB-1940,…

Boulder, CO, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Think Bioscience (“Think”), a synthetic biology company focused on developing small-molecule therapeutics that target difficult-to-drug proteins, has raised $17M in an oversubscribed Seed…

The number of potential therapeutic targets on the surfaces of human proteins is much greater than previously thought, according to the findings of a new study in the journal Nature. A ground-breaking new technique developed by researchers…

The FDA granted accelerated approval to sotorasib (Lumakras) on Friday as a second-line agent for non-small cell lung cancer (NSCLC) harboring…